Full-Time

Director Human Resources

Posted on 8/14/2025

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$151.4k - $160k/yr

+ Bonus

San Diego, CA, USA

In Person

Category
People & HR (1)
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree in Human Resources, Business, Industrial Relations, or a related field required
  • Minimum 10 years of HR experience, including at least 5 years in an HR leadership role within life science, manufacturing or industrial environments
  • In-depth understanding of manufacturing operations and hourly workforce dynamics in a production environment
  • Experience within multi-national organization
  • Career history of setting clear targets aligned to business goals and achieving them through others
  • Proven expertise in labor relations, workforce planning, leadership development, and talent optimization across the full employee life cycle
  • Ability to influence stakeholders at all levels and navigate complex, evolving environments
  • Strong change leadership and project management capabilities
  • Success achieving results through collaboration and partnership within a matrixed organizational structure
  • Proficiency in HR systems (e.g., Workday) and workforce analytics
Responsibilities
  • Define and lead human resources strategies across a network of PCI sites and/or functions
  • Collaborate closely with Site and Functional Leadership teams to enhance productivity, employee engagement, and organizational capability
  • In partnership with PCI’s HR Centers of Excellence, oversee and integrate successfully the full talent lifecycle, including recruitment strategies, organizational design and development, succession planning, and internal mobility for key roles
  • Provide oversight on employee relations and labor matters
  • Promote a high-performance culture by championing employee engagement, equality and inclusion, strong communication channels and forums as well as recognition and well-being initiatives
  • Ensure adherence to applicable employment laws and regulatory requirements in all jurisdictions of operation
  • Lead HR components of organizational change such as mergers and acquisitions, new site openings, or restructuring initiatives
  • Lead, mentor, and develop HR Teams across sites and/or functional teams
  • Leverage data and analytics to drive evidence-based decision-making, assess HR effectiveness, and monitor workforce trends, retention, and resource planning
  • Serve as a strategic advisor within senior leadership teams, influencing decisions that impact business outcomes, operational excellence, safety and long-term success
  • Anticipate and prepare accordingly to manage growth
  • Promote environmentally and socially responsible HR practices aligned with corporate ESG goals

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE